Collaboration Inquiries
Latest News Press Release Recent Articles Current & Upcoming Meetings and Events Past Meetings and Events
Contact Information
VacciMax® Platform Advantage VacciMax® Proof of Concept VacciMax® Platform Scale-up
Board of Directors Corporate Profile In Memorium Scientific Advisors Senior Management Technical Advisors
Contact Us Partners Press Releases Spayvac Vaccimax Corporate Profile Home
  HOME | PROFILE | VACCIMAX® PLATFORM | PRESS | PARTNERS | CAREERS | CONTACT  


Delivering Breakthrough Vaccines

IVT’s goal is to generate sustainable, long-term revenues by developing and commercializing VacciMax® based vaccines through early clinical development, multiple partnerships and licensing agreements with major vaccine companies.

LATEST NEWS

Vaccine Development Aided by New Techniques

On The Move - ImmunoVaccine Technologis Inc. has been selected as one of Canada's Top 10 Life Sciences Companies

Vaccine breakthrough heralds new cancer treatment

ImmunoVaccine Technologies’ DepoVax™ Shows Positive Results for Cancer and Infectious Diseases

ImmunoVaccine Technologies selected as Canada's Top 10™ Life Sciences Companies

 

IN MEMORIUM

 

 

Dr. Warwick Kimmins

Co-Founder and Past Chairman

 

Dr. Warwick Kimmins passed away on August 5th, 2007.  Dr. Kimmins was an engaged scientist that was instrumental in bringing IVT to where it is today and those of us who knew him are deeply saddened by his passing.


 

 

 

 

 

 

 

 

 

 

 

 

 

  HOME | PROFILE | PRODUCT | PRESS | PARTNERS | CAREERS | CONTACT